How to find the optimal partner—studies of snurportin 1 interactions with U snRNA 5′ TMG-cap analogues containing modified 2-amino group of 7-methylguanosine
Snurportin 1 is an adaptor protein that mediates the active nuclear import of uridine-rich small nuclear RNAs (U snRNA) by the importin-b receptor pathway. Its cellular activity influences the overall transport yield of small ribonucleoprotein complexes containing N-2,N-2,7-trimethylguanosine (TMG) capped U snRNA. So far little is still known about structural requirements related to molecular recognition of the trimethylguanosine moiety by snurportin in solution. Since these interactions are of a great biomedical importance, we synthesized a series of new 7-methylguanosine cap analogues with extended substituents at the exocyclic 2-amino group to gain a deeper insight into how the TMG-cap is adapted into the snurportin cap-binding pocket. Prepared chemical tools were applied in binding assays using emission spectroscopy. Surprisingly, our results revealed strict selectivity of snurportin towards the TMG-cap structure that relied mainly on its structural stiffness and compactness. (C) 2015 Elsevier Ltd. All rights reserved.
Synthesis and evaluation of stability of m3G-CAP analogues in serum-supplemented medium and cytosolic extract
作者:Malgorzata Honcharenko、Malgorzata Zytek、Burcu Bestas、Pedro Moreno、Jacek Jemielity、Edward Darzynkiewicz、C.I. Edvard Smith、Roger Strömberg
DOI:10.1016/j.bmc.2013.10.002
日期:2013.12
Increased efficiency in splice-correction (splice-switching) has been shown by use of a synthetic RNA 5' end nuclear localization signal composed of an m(3)G-CAP. Use of the m(3)G-CAP as an NLS signal for therapeutic compounds in vivo is likely to require additional stability towards enzymatic degradation. For this reason introduction of stabilizing modifications into the triphosphate bridge may be beneficial. Here we report on synthesis of three m(3)G-CAP derivatives with a 'native' (m(3)GpppA(OMe)) as well as with a methylenephosphonate stabilized triphosphate bridge (m(3)GpCH(2)ppA(OMe), m(3)GppCH(2)pA(OMe)) and the investigation of the enzymatic stability of these compounds in 10% (v/v) fetal bovine serum (FBS) and cytosolic extract from HeLa cells, thus mimicking in vivo conditions. Our results indicate that introduction of methylene group between the beta and gamma phosphates in m(3)GpCH(2)ppAOMe improves to some extent stability of this analogue in 10% serum but does not prolong life of this compound in the cytosolic extract. In contrast the stabilization introduced between alpha and beta phosphates in m(3)GppCH(2)pAOMe offers threefold longer life in 10% serum and almost complete protection in cytosolic extract. (C) 2013 Elsevier Ltd. All rights reserved.
5′-Terminal chemical capping of spliced leader RNAs
作者:Karolina Piecyk、Richard E. Davis、Marzena Jankowska-Anyszka
DOI:10.1016/j.tetlet.2012.06.127
日期:2012.9
Spliced leader (SL) RNA trans-splicing adds a N-2,N-2,7-trimethylguanosine cap (TMG) and a 22-nucleotide sequence, the SL, to the 5' end of mRNAs. Both non-trans-spliced with a monomethylguanosine cap (MMG) and trans-spliced mRNAs co-exist in trans-splicing metazoan cells. Efficient translation of TMG-capped mRNAs in nematodes requires a defined core of nucleotides within the SL sequence. Here we present a chemical procedure for the preparation and purification of 5'-terminal capped MMG and TMG wild-type, and mutant 22 nt spliced leader RNAs (GGU/ACUUAAUUACCCAAGUUUGAG) with or without a 3' biotin tag. (C) 2012 Elsevier Ltd. All rights reserved.